A clinical phase III comparative, randomised, clinical trial to assess the safety and efficacy of a fixed dose of oral pyronaridine-artesunate granule formulation (60:20) (paediatric Pyramax) versus artemether-lumefantrine (Coartem) crushed tablets in infants and children with acute uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon

DSpace Repositorium (Manakin basiert)

A clinical phase III comparative, randomised, clinical trial to assess the safety and efficacy of a fixed dose of oral pyronaridine-artesunate granule formulation (60:20) (paediatric Pyramax) versus artemether-lumefantrine (Coartem) crushed tablets in infants and children with acute uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon

Autor(en): Salazar, Pablo de
Tübinger Autor(en):
Salazar, Pablo de
Sonstige Beteiligte: Eberhard Karls Universität Tübingen
Erscheinungsjahr: 2016
Verlagsangabe: Tübingen
Sprache: Englisch
Referenz zum Volltext: http://nbn-resolving.de/urn:nbn:de:bsz:21-dspace-757521
DDC-Klassifikation: 610 - Medizin, Gesundheit
Dokumentart: Dissertation
Seitenzahl: 83 Seiten : Illustrationen
Verbund-Nachweis: 486502368
486502163
Kommentar: Dissertation, Eberhard Karls Universität Tübingen, 2016; Erscheint auch als, Online-Ausgabe, Salazar, Pablo de, 1982 - , A clinical phase III comparative, randomised, clinical trial to assess the safety and efficacy of a fixed dose of oral pyronaridine-artesunate granule formulation (60:20) (paediatric Pyramax) versus artemether-lumefantrine (Coartem) crushed tablets in infants and children with acute uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon, Tübingen, 2017, 1 Online-Ressource (83 Seiten),
Zur Langanzeige

Das Dokument erscheint in: